메뉴 건너뛰기
Journal of Clinical Oncology
Volumn 23, Issue 22, 2005, Pages 4821-4822
High bone turnover markers predict poor outcome in patients with bone metastasis
Author keywords

[No Author keywords available]
Indexed keywords

ALKALINE PHOSPHATASE; AMINO TERMINAL TELOPEPTIDE; ANALGESIC AGENT; ANTINEOPLASTIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; TUMOR MARKER;
EID: 24644440599     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.02.911     Document Type: Editorial
Times cited : (15)
References (6)
  • 1
    • 4644261592 scopus 로고    scopus 로고
    • Mechanisms of bone metastasis
    • Roodman GD: Mechanisms of bone metastasis. N Engl J Med 350: 1665-1664, 2004
    • (2004) N Engl J Med , vol.350 , pp. 1665-1664
    • Roodman, G.D.1
  • 2
    • 19944432878 scopus 로고    scopus 로고
    • Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors
    • Brown JE, Cook RJ, Major P, et al: Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors. J Natl Cancer Inst 97:59-69, 2005
    • (2005) J Natl Cancer Inst , vol.97 , pp. 59-69
    • Brown, J.E.1    Cook, R.J.2    Major, P.3
  • 3
    • 24644479228 scopus 로고    scopus 로고
    • The predictive value of bone resorption and formation markers in cancer patients with bone metastases receiving the bisphosphonate zoledronic acid
    • Coleman RE, Major P, Lipton A, et al: The predictive value of bone resorption and formation markers in cancer patients with bone metastases receiving the bisphosphonate zoledronic acid. J Clin Oncol 23:4925-4935, 2005
    • (2005) J Clin Oncol , vol.23 , pp. 4925-4935
    • Coleman, R.E.1    Major, P.2    Lipton, A.3
  • 4
    • 0242308942 scopus 로고    scopus 로고
    • Zoledronic acid treatment of 5T2MM-bearing mice inhibits the development of myeloma bone disease: Evidence for decreased osteolysis, tumor burden and angiogenesis, and increased survival
    • Croucher PI, DeHendrik R, Perry MJ, et al: Zoledronic acid treatment of 5T2MM-bearing mice inhibits the development of myeloma bone disease: Evidence for decreased osteolysis, tumor burden and angiogenesis, and increased survival. J Bone Miner Res 18:482-492, 2003
    • (2003) J Bone Miner Res , vol.18 , pp. 482-492
    • Croucher, P.I.1    DeHendrik, R.2    Perry, M.J.3
  • 5
    • 0036181668 scopus 로고    scopus 로고
    • Myeloma interacts with the bone marrow microenvironment to induce osteoclastogenesis and is dependent on osteoclast activity
    • Yaccoby S, Pearse RN, Johnson CL, et al: Myeloma interacts with the bone marrow microenvironment to induce osteoclastogenesis and is dependent on osteoclast activity. Br J Haematol 116:278-290, 2002
    • (2002) Br J Haematol , vol.116 , pp. 278-290
    • Yaccoby, S.1    Pearse, R.N.2    Johnson, C.L.3
  • 6
    • 12344250046 scopus 로고    scopus 로고
    • Evaluation of the clinical value of bone metabolic parameters for the screening of osseous metastases compared to bone scintigraphy
    • Schoenberger J, Rozeboom S, Wirthgen-Beyer E, et al: Evaluation of the clinical value of bone metabolic parameters for the screening of osseous metastases compared to bone scintigraphy. BMC Nucl Med 4:3, 2004
    • (2004) BMC Nucl Med , vol.4 , pp. 3
    • Schoenberger, J.1    Rozeboom, S.2    Wirthgen-Beyer, E.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.